Serum proteomic profiling reveals MTA2 and AGO2 as potential prognostic biomarkers associated with disease activity and adverse outcomes in multiple myeloma.

Serum proteomic profiling reveals MTA2 and AGO2 as potential prognostic biomarkers associated with disease activity and adverse outcomes in multiple myeloma.

Show other versions (1)

Multiple myeloma (MM) is an incurable plasma cell malignancy accounting for approximately 10% of hematological malignancies. Identification of reliable biomarkers for better diagnosis and prognosis remains a major challenge. This study aimed to identify potential serum prognostic biomarkers correspo...

Full description

Bibliographic Details
Main Authors: Dollapak Apipongrat, Sittiruk Roytrakul, Kannadit Prayongratana, Mongkon Charoenpitakchai, Kamphon Intharanut, Chonlada Laoruangroj, Panachai Silpsamrit, Oytip Nathalang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0278464

Internet

https://doi.org/10.1371/journal.pone.0278464

Similar Items